Disease-free Survival Rate
1 clinical trials · Condition
◉ Watch Disease-free Survival Rate
| Record | Firm | Date |
|---|---|---|
| Phase Ⅱ Trial of Camrelizumab in Patients Without Distant Metastasis Nasopharyngeal Carcinoma (NCT04782765) | Tianjin Medical University Cancer Institute and Hospital | 2021-03-20 |
Track Disease-free Survival Rate automatically
Every clearance here is in the API, with alerts when new ones post.